Patient-reported outcomes in studies of STereotactic arrhythmia Radioablation for ventricular tachycardia (PRO-STAR) - A scoping review on behalf of the STOPSTORM.Eu consortium.

Although quality of life is a key outcome in cardiovascular disease, it is unclear how Patient-Reported Outcomes (PROs) are employed in trials of STereotactic Arrhythmia Radioablation (STAR). We conducted a scoping review and found that only 55% of STAR trials employ PROs and that these were almost exclusively generic measures.